Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.bios.2010.07.123
Title: Development of biocompatible SERS nanotag with increased stability by chemisorption of reporter molecule for in vivo cancer detection
Authors: Maiti, K.K.
Dinish, U.S.
Fu, C.Y.
Lee, J.-J.
Soh, K.-S.
Yun, S.-W.
Bhuvaneswari, R.
Olivo, M. 
Chang, Y.-T. 
Keywords: Biocompatible nanoparticle tag
Cancer marker
Cellular imaging
Raman reporters
Surface-enhanced Raman scattering (SERS)
Issue Date: Oct-2010
Citation: Maiti, K.K., Dinish, U.S., Fu, C.Y., Lee, J.-J., Soh, K.-S., Yun, S.-W., Bhuvaneswari, R., Olivo, M., Chang, Y.-T. (2010-10). Development of biocompatible SERS nanotag with increased stability by chemisorption of reporter molecule for in vivo cancer detection. Biosensors and Bioelectronics 26 (2) : 398-403. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bios.2010.07.123
Abstract: Biocompatible surface-enhanced Raman scattering (SERS) nanotag has been developed by chemisorption of novel Raman reporters on gold colloid. We modified our previously published best five reporter molecules (B2, B7, C3, C7 and C9) from triphenylmethine (TM) library using lipoic acid (LA) as a linker to covalently attach the reporters on gold colloid. Among these TM-LA molecules, B2LA showed the highest SERS signal intensity and stability over time. Further, time course SERS intensity of B2LA was compared with currently popular Raman reporter malachite green isothiocyanate (MGITC). The results demonstrated that signal intensity from B2LA was even stable over a period of one month. In vitro SERS screening was performed in cancer cell lines using B2LA containing nanotag conjugated with selective antibodies recognizing HER2 and EGFR cancer proteins. We found reasonably strong SERS signals from both HER2 and EGFR positive cells whereas no signal was measured from respective negative cells. Moreover, we successfully proved this recognition by cell imaging using fluorescein isothiocyanate (FITC) labeled antibody conjugated nanotag. Both SERS and cell-imaging study further confirmed the selective binding of antibody conjugated nanotag to cancer cells over-expressing HER2 and EGFR. In addition, as a proof of concept, in vivo SERS measurement in a mouse model was carried out to detect the nanotag-anchored cancer cells that are subcutaneously injected to the animal. © 2010 Elsevier B.V.
Source Title: Biosensors and Bioelectronics
URI: http://scholarbank.nus.edu.sg/handle/10635/75931
ISSN: 09565663
DOI: 10.1016/j.bios.2010.07.123
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

82
checked on Sep 22, 2018

WEB OF SCIENCETM
Citations

75
checked on Sep 12, 2018

Page view(s)

39
checked on May 4, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.